Author: Alexia Armstrong

Enhanced Cryopreservation of Therapeutically Relevant Cells

By

Reduced-DMSO cryopreservation workflows often compromise post-thaw viability, expansion, and functional cell attributes due to increased cellular stress during freeze/thaw. In a comparative study across T cells, mesenchymal stem cells (MSCs), and induced pluripotent stem cells (iPSCs), InVitria® evaluated whether recombinant human serum albumin (rHSA) could improve cryopreservation performance relative to plasma-derived HSA (pHSA) and albumin-free …

InVitria Presents ASGCT 2026 Data on rHSA for Lentiviral Vector Manufacturing

By

FOR IMMEDIATE RELEASE InVitria Presents New Data at ASGCT 2026 on Recombinant Human Serum Albumin for Higher Lentiviral Vector Titers and Improved Cell Therapy Manufacturing JUNCTION CITY, Kan., May 12, 2026 — InVitria, a global leader in chemically defined, animal-origin-free recombinant proteins for advanced therapy manufacturing, announced its participation in the American Society of Gene …

InVitria Showcases Exbumin and Optibumin 25 at IPEC Excipient World: Biologics Summit

By

FOR IMMEDIATE RELEASE Junction City, KS – April 29, 2026 – InVitria, a global leader in chemically defined, animal origin free recombinant proteins for biologics manufacturing, today announced its participation in the IPEC Excipient World Biologics Summit, taking place May 4-6, 2026 in Nashville, TN. The company will highlight its recombinant human serum albumin (rHSA) portfolio, designed to enhance formulation stability, consistency, and performance in injectable biologics, vaccines, …

Recombinant Albumin Preserves Dilute Cytokine Recovery and Bioactivity at Room Temperature

By

Dilute cytokines lose activity during routine handling because of surface adsorption, aggregation, and oxidative degradation — losses that introduce variability into cell therapy and biomanufacturing workflows. In a 4-week stability study across refrigerated (2–8°C), room-temperature, and elevated (35–40°C) conditions, InVitria® evaluated whether Optibumin® 25, a recombinant human serum albumin (rHSA) produced in a non-mammalian expression …